Expansion opportunity with limited stakeholder coverage.
Aster Clinical is entering a new therapeutic area. Historical delivery performance is strong, but engagement remains concentrated within one operational team.
Supporting evidence Open a source to investigate
Consistent delivery across existing programsDelivery records · Documented fact
Source: Program milestone register. 23 of 25 agreed milestones were delivered on time across two existing programs. This supports delivery strength; it does not establish demand for additional services.
Expansion into a new therapeutic areaCustomer strategy update · Documented fact
Source: Customer strategy update. The customer has documented a planned move into immunology. Timing, buying authority, and specific service needs have not been established.
Relationships concentrated in one teamRelationship history + Discovery · Record and perspective
Sources: Account activity and account lead Discovery interview. Recorded meetings involve the existing project team. The account lead reports limited contact with decision-makers in the new area. This perspective needs validation with the customer.
No strategic opportunity discussion recordedAvailable account history · Evidence gap
Source: Available account meeting records. No discussion of the new opportunity is documented. An absent record does not prove a discussion never happened. Confirm with the account team and customer.
Interpretation: a potential opportunity worth investigating. Customer need and stakeholder influence remain unconfirmed.